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RESEARCH
Military personnel are at high risk of contracting vec-
tor-borne and zoonotic infections, particularly during over-
seas deployments, when they may be exposed to endemic 
or emerging infections not prevalent in their native coun-
tries. We conducted seroprevalence testing of 467 UK mil-
itary personnel deployed to Helmand Province, Afghani-
stan, during 2008–2011 and found that up to 3.1% showed 
seroconversion for infection with Rickettsia spp., Coxiella 
burnetii, sandfly fever virus, or hantavirus; none showed 
seroconversion for infection with Crimean-Congo hemor-
rhagic fever virus. Most seroconversions occurred in per-
sonnel who did not report illness, except for those with 
hantavirus (70% symptomatic). These results indicate 
that many exposures to infectious pathogens, and poten-
tially infections resulting from those exposures, may go 
unreported. Our findings reinforce the need for contin-
ued surveillance of military personnel and for education 
of health care providers to help recognize and prevent ill-
nesses and transmission of pathogens during and after 
overseas deployments.
Military personnel represent a population that travel to and work in environments where they are exposed 
to endemic or emerging infections that are not prevalent 
in their native country. Groups of military personnel on in-
ternational deployments thus form a useful naive sentinel 
group for infectious diseases; these groups may serve as 
indicators of the infectious disease agents to which the lo-
cal populations are exposed and of the diseases that may 
be encountered by other visitors traveling to the area (e.g., 
tourists, as well as staff of nongovernmental organizations, 
aid organizations, and other government agencies). Study 
of infectious disease exposures and illnesses among mili-
tary personnel may provide insight into the epidemiology 
of emerging and reemerging infections and highlight what 
pathogens could be imported back to the home nations of 
visitors to these areas.
The recognition that military personnel may act as dis-
ease sentinels is not a new concept. Infectious diseases have 
beleaguered international military operations for centuries, 
with historic campaigns facing substantial loss of life after 
soldiers succumbed to infections endemic to the areas in 
which they were operating at the time (1). Examples from 
British military history include many diseases that may be 
categorized as “undifferentiated febrile illnesses” (2). The 
causative agents for these fevers, often unidentified at the 
time they occurred, were predominantly infectious patho-
gens established in the geographic area in which troops 
were operating. For example, in the late 19th century, the 
zoonotic disease brucellosis and the vector-borne parasitic 
diseases leishmaniasis and malaria were common in Brit-
ish colonial troops deployed to the tropics and subtropics. 
In India, 24% of troops were admitted to the hospital for 
malaria in 1908 alone (3). During World War I, cases of 
leptospirosis (4) and trench nephritis (in retrospect thought 
to be caused by hantavirus, which resulted in >35,000 ill-
nesses) (5) were also documented.
More recently, since World War II, UK military opera-
tions in Korea, Malaya, Borneo, Sierra Leone, Liberia, East 
Timor, and Haiti have resulted in illnesses among military 
personnel caused by vector-borne pathogens; these illness-
es have included Japanese encephalitis, malaria, and den-
gue (2,6). This incidence of infectious disease is not limited 
to the tropics; campaigns in the Balkans and the Arabian 
Gulf during the past 25 years resulted in reports of cases of 
a range of vector-borne and zoonotic infections (7–9).
Although information about endemic infectious dis-
ease in Afghanistan is limited, previous historical reports 
indicate that several endemic vector-borne and zoonotic 
diseases, including rickettsial diseases, Crimean-Congo 
hemorrhagic fever (CCHF), and pappataci fever (now 
known as sandfly fever) (10). Given the country’s geo-
graphic location, other pathogens endemic to the central 
Asian region could also be expected to be of concern to 
military personnel; these pathogens include Sindbis, chi-
kungunya, and West Nile fever viruses (11). Although in-
fections with many of these pathogens can be prevented 
by drugs (chemoprophylaxis) or vaccination, and the risk 
for exposure can often be reduced by physical measures, 
the ongoing UK military campaign in Afghanistan has still 
resulted in infectious diseases occurring in deployed per-
sonnel. Severe cases have required restrictions of duties or 
even hospitalization or evacuation to the United Kingdom, 
and high illness rates can affect the operational capability 
of the military force (12).
In 2011, Bailey et al. documented numerous cases of 
“undifferentiated febrile illness” in British military per-
sonnel serving in Helmand Province, Afghanistan, during 
the summer of 2008 (13). These cases, for which no organ 
focus could be determined on clinical and radiologic as-
sessment and no positive results were obtained from micro-
biological investigations (e.g., blood cultures and malaria 
antigen tests), have been given the colloquial term “Hel-
mand fever.”
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For this study, we conducted surveillance among UK 
military personnel to determine the prevalence of sev-
eral vector-borne or zoonotic infectious agents that were 
suspected to be the causative agents of some of these 
cases of undifferentiated fever: Rickettsia spp., Coxiella 
burnetii, sandfly fever virus, hantavirus, and CCHF vi-
rus (CCHFV). We conducted serosurveillance testing of 
467 military service members who were deployed to Hel-
mand Province during March 2008–October 2011. In this 
article, we describe the pathogens for which study par-
ticipants showed seroconversion before and after a tour 
of duty and the incidence of those seroconversions within 
the military population.
Methods
Recruitment and Sampling
Study volunteers were recruited from either British 
Army regiments or Royal Marines units before deployment 
to Helmand Province, Afghanistan. For each deployment, a 
research nurse visited the unit and gave study information 
to the troops. Volunteers were required to give informed 
consent and to have 1 predeployment blood sample taken. 
After return from the 6-month tour of duty, volunteers were 
visited and asked to give a second postdeployment blood 
sample. At the postdeployment visit, volunteers were also 
asked to complete a short questionnaire detailing any “flu-
like” illness or symptoms they experienced while deployed 
and any contact they had with livestock, wildlife, or insect 
vectors. The primary location of each company (i.e., group 
of ≈100 personnel in which the volunteer was posted) while 
deployed was also noted. Ethical approval for this survey 
was provided by the UK National Health Service National 
Research Ethics Service and Ministry of Defence Research 
Ethics Committee.
Blood samples were taken by venipuncture using 
BD SSTII Advance 10-mL vacutainers (Becton Dickin-
son, Oxford, UK). After a minimum 30-min incubation at 
room temperature, samples were centrifuged at 3,500 
rpm for 15 min to separate the serum. This serum fraction 
was then separated and stored at -80°C for subsequent se-
rologic testing.
During the study period, March 2008–October 
2011, a total of 467 volunteers gave paired serum sam-
ples (i.e., predeployment and postdeployment samples). 
In all cases, samples were kept anonymous (by unique 
identification numbers), and questionnaire data/confi-
dential information were kept in a secure database with 
restricted access. 
Serologic Testing
Postdeployment samples were tested first for antibod-
ies to all pathogens of interest. If results were positive, the 
corresponding predeployment sample was then tested to 
ascertain whether the volunteer seroconverted during the 
tour of duty for which they were recruited to the study or 
if they were already seropositive (i.e., exposed/seroconver-
ted to that pathogen) before being recruited for the study. 
A volunteer whose sample was negative before deploy-
ment but positive after deployment was deemed to have 
seroconverted during that particular tour of duty. For each 
pathogen of interest, diagnostic tests were used in line with 
Public Health England’s diagnostic laboratory procedures. 
All assays used have been validated locally for diagnostic 
use, are approved by UK regulatory authorities, and have 
been awarded Communauté Européenne marking by the 
European Union.
C. burnetii ELISA
Antibodies against C. burnetii, the causative agent 
of Q fever, were detected by using a commercial ELISA 
to detect phase 2 IgG and IgM human antibodies (Serion/
Virion, Würzburg, Germany). ELISAs were conducted by 
using the DS2 Automated ELISA workstation (DYNEX 
Magellan Biosciences, Chantilly, VA, USA) according to 
the manufacturer’s instructions. All serum samples were 
tested at an initial dilution of 1:100, as recommended by 
the manufacturer’s product insert for diagnostic samples. 
If results were calculated as positive (above the automated 
threshold on DS2 software) for either IgG or IgM, the test 
was repeated in duplicate for confirmation. Because of the 
nonacute nature of the survey, all samples showing at least 
Phase 2 IgG positivity were deemed positive.
Hantavirus Immunofluorescence Assay (IFA)
Antibodies against the hantavirus group of pathogens 
were detected by using a commercial Hantavirus IIFT Mo-
saic 1 IgG IFA (Euroimmun, Lübeck, Germany). All serum 
samples were tested at an initial dilution of 1:100, as rec-
ommended by the manufacturer’s product insert for diag-
nostic samples. If results were calculated as positive (for 
any species/subspecies of hantavirus), the test was repeated 
and confirmed by using the Recomline Bunyavirus IgG/
IgM Line Assay (Mikrogen, Neuried, Germany). All IFA 
slides were set up by using the AP16 IF Plus automated 
slide processor (Euroimmun) and viewed by using a con-
ventional fluorescent light microscope.
Rickettsia IFA
Antibodies against Rickettsia spp. were detected by us-
ing a commercial Rickettsia IgG and IgM IFA (Focus Diag-
nostics, Cypress, CA, USA). This assay is specific for rick-
ettsial infection; that is, antibodies against Coxiella spp. do 
not cross-react in this test (Public Health England, unpub. 
data). All serum samples were tested at an initial dilution of 
1:64, as recommended by the manufacturer’s product insert 
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for diagnostic samples. If results were calculated as posi-
tive, the test were repeated and confirmed by titrating down 
a 2-fold dilution series to 1:512 (data not shown) to ensure 
that fluorescence diminished with antibody dilution (as rec-
ommended in the product insert). Because samples were 
not obtained during an acute illness phase, any sample that 
showed a consistent signal at 1:64 dilution was considered 
to be positive, even if this diminished by the 1:128 dilution. 
All IFA slides were prepared in accordance with the manu-
facturer’s instructions and viewed by using a conventional 
fluorescent light microscope
Sandfly Fever Virus IFA
Antibodies against sandfly fever viruses (genus Phlebo-
virus) were detected in serum by using a commercial sandfly 
fever assay (IIFT Mosaic 1 IgG immunofluorescence assay; 
Euroimmun). All serum samples were tested at a dilution 
of 1:100, as recommended by the manufacturer’s product 
insert for diagnostic samples. Given the nonacute nature of 
the samples, a positive result was defined as any sample that 
showed a consistent signal (for any of the 4 species/strains 
of sandfly fever virus) at 1:100 dilution. All IFA slides were 
set up by using the AP16 IF Plus automated slide processor 
(Euroimmun) and viewed by using a conventional fluores-
cent light microscope.
Crimean-Congo Hemorrhagic Fever ELISA
Antibodies against CCHFV nucleoprotein were detect-
ed by using an in-house CCHF recombinant ELISA (14). 
ELISAs were carried out by using the DS2 Automated 
ELISA workstation (DYNEX Magellan Biosciences). All 
serum samples were tested at an initial dilution of 1:100, 
and any tests that gave any signal above background were 
repeated in duplicate.
Results
The Table shows the results of the respective serol-
ogy assays performed. For each pathogen (with the ex-
ception of CCHFV, for which no seroprevalence was 
reported), 2 categories of a seropositive volunteer were 
identified: those who showed detectable levels of anti-
body before and after deployment; and those who only 
showed positivity on return, with no detectable antibody 
in predeployment samples. During deployment, the troops 
showed the highest seroconversion rates for sandfly fever 
virus (3.1%) and rickettsiae (2.7%). However, serocon-
versions for hantavirus and C. burnetii (1.3% and 1.7%, 
respectively) also occurred.
The group of volunteers who were positive for each 
pathogen before deployment showed that there was a back-
ground level of seroprevalence for these pathogens within 
the UK military. The group of initially antibody-negative 
personnel seroconverted to the pathogens while on deploy-
ment, which suggests that military personnel are being ex-
posed to such diseases while on operations in Afghanistan 
and that these diseases are being transmitted in the region. 
Figure 1 shows the prevalence of volunteers who sero-
converted during each deployment period. This comparison 
enabled us to plot prevalence as a function of season: win-
ter deployments (October–March) compared with summer 
deployments (March–October). This analysis showed a 
higher prevalence of seroconversion in the Northern Hemi-
sphere summer months, when the deployment area is hotter 
and drier than over the winter. Sandfly fever virus showed 
the greatest seasonal variation, with most cases in the sum-
mer months, and C. burnetii showed the least variations, 
findings that are consistent with these pathogens’ known 
modes of transmission.
Many seroconversions for the studied pathogens ap-
peared to be asymptomatic. All volunteers took part in a 
return questionnaire when the postdeployment sample was 
taken. This questionnaire was used to determine whether 
those who seroconverted after deployment experienced a 
“flu-like” illness during deployment. Figure 2 shows that, 
for all 4 pathogens acquired (Rickettsia spp., C. burnetii, 
sandfly fever virus, and hantavirus), a proportion of volun-
teers showed seroconversion but did not report feeling ill. 
As expected, sandfly fever virus and rickettsial infections 
showed the highest proportion of asymptomatic cases; just 
6.5% and 7.4%, respectively, of those who seroconverted 
reporting feeling ill (i.e., 93.5% of sandfly fever virus expo-
sures and 92.6% of Rickettsia spp. exposures were asymp-
tomatic). The less common but often more clinically signif-
icant pathogens hantavirus and C. burnetii resulted in more 
reports of illness; 64.7% of C. burnetii seroconversions and 
30.8% of hantavirus seroconversions were asymptomatic.
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Table. Results of antibody testing for 5 infectious pathogens among UK service personnel before and after deployment to Helmand 
Province, Afghanistan, March 2008–October 2011* 
Pathogen No. persons tested No. (%) with detectable antibody before deployment No. (%) with seroconversion after deployment Total no. (%) with positive antibody test 
CCHFV 466 0 0 0 
Sandfly fever virus 459 8 (1.7) 14 (3.1) 22 (4.8) 
Rickettsia spp. 446 10 (2.2) 12 (2.7) 22 (4.9) 
Hantavirus 453 5 (1.1) 6 (1.3) 11 (2.4) 
Coxiella burnetii 467 7 (1.5) 8 (1.7) 15 (3.2) 
*Assays were run sequentially on samples from all persons tested; some sample sizes were insufficient for testing for all agents. CCHFV, Crimean-Congo 
hemorrhagic fever virus. 
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Postdeployment questionnaires showed that nearly one 
fifth (90/467, 19.3%) of all volunteers reported experienc-
ing “flu-like” symptoms while on operations in Helmand 
Province. A total of 56.7% of those who recorded >1 epi-
sodes of feeling unwell reported experiencing fever only, 
whereas 12.2% had no additional/specific symptoms; the 
remaining 31.2% reported either diarrhea and vomiting 
(15.6%) or “other” symptoms (Figure 3).
Discussion
UK military personnel consist of ≈237,190 persons 
(estimate of combined regular and volunteer reserve mil-
itary personnel in UK, 2010 [UK Ministry of Defence, 
unpub. data]). Our results show that military person-
nel are being exposed to, at minimum, Rickettsia spp., 
C. burnetii, sandfly fever virus, and hantaviruses while 
on operations in Afghanistan, a region where these agents 
and resulting diseases are endemic. These results suggest 
that human or animal (for the zoonotic pathogens) reser-
voirs likely exist in the local populations of the Helmand 
region for these diseases.
Troops often patrol through vegetation and farm land 
where both reservoir and vector populations are high, which 
can easily result in exposure to pathogens and further sup-
ports the hypothesis that the nature of their work makes 
armed forces personnel a group with an increased incidence 
of exposure to such vector-borne or zoonotic pathogens. 
However, this group may also act as a good sentinel cohort 
for other populations of nonindigenous workers from gov-
ernmental and nongovernmental organizations. 
UK troops do sometimes stop over at British military 
bases in Cyprus during their return to the United Kingdom. 
However, these stopovers are typically very short in dura-
tion (2–3 days), and they do not occur in an environment 
where exposure is likely to occur, with the possible excep-
tion of sandfly bites. In addition, for each pathogen studied, 
a proportion of troops showed antibody positivity before 
deployment, suggesting that they may have been exposed 
to these pathogens on previous deployments to Afghanistan 
(before being recruited to the study) or on other exercises 
and operations around the world.
Overall, seroprevalence for these pathogens appears 
to be low, although this is hard to determine without a 
comprehensive study of nondeploying troops. These re-
sults may reflect good discipline or education of UK 
troops in the use of personal protection measures such 
as the use of DEET-containing insect repellent and mos-
quito nets, both of which are actively promoted by the 
UK military. A higher proportion of those deployed over 
the summer months showed seroconversion, correspond-
ing with an increase in the numbers of biting vectors such 
as the Phlebotomus sandfly and ticks (rickettsial vectors). 
Further study of seasonality might show whether these 
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Figure 1. Results of antibody 
testing for 4 infectious pathogens, 
by tour of duty, among 467 UK 
service personnel deployed to 
Helmand Province, Afghanistan, 
March 2008–October 2011. 
n values indicate number of 
volunteers tested from each 
tour of duty. Assays were run 
sequentially on samples from all 
persons tested; some sample 
sizes were insufficient for testing 
for all agents.
Figure 2. Percentages of UK service personnel who sero-converted 
to 1 of 5 infectious pathogens who reported feeling unwell or did not 
report illness during deployment to Helmand Province, Afghanistan, 
March 2008–October 2011. A total of 90 (19.3%) of 467 deployed 
service members reported feeling unwell during deployment. CCHFV, 
Crimean-Congo hemorrhagic fever virus; SFFV, sandfly fever virus.
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increases correlate with increased military activity (e.g., 
military patrolling and combat operations increase during 
the summer months), environmental/entomologic chang-
es (e.g., decreases in rain and/or increases in temperature 
conditions favorable to agent, reservoir, or host density), 
or possible lapses in discipline regarding personal protec-
tive measures. 
At first glance, summer seasonality may seem odd for 
an increase in hantavirus seroconversion, for which inci-
dence would be more likely to correlate with closer prox-
imity of humans with the rodent reservoir. However, UK 
summer deployments extend to late September and in some 
cases the first week or two of October; thus, these deploy-
ment continue into early autumn, when rodents are actively 
moving into buildings. In addition, the apparent lack of 
rickettsial infections after summer 2010 raises questions 
of whether this might correlate with a change in vector 
life-cycle, abundance of reservoir species, changes in in-
sect bite prevention regimens, or changes to local livestock 
management regimens.
The increased incidence of rickettsial and sandfly fever 
virus infections that we found among deployed troops does 
not necessarily mean that these vector-borne pathogens 
are more prevalent in the environment and local popula-
tion than the zoonotic pathogens C. burnetii or hantavirus. 
Rather, these results may mean that mode of transmission 
and incidence of encounters with the vectors and reservoirs 
differ. However, our results do indicate that these patho-
gens may pose the greatest risk to UK troops.
Although most of the diseases we detected are rela-
tively self-limiting after the initial acute infection, our 
results suggest ways to improve control measures to reduce 
the rate of transmission. UK military personnel are already 
given medical advice and education before deployment, 
emphasizing the prevention of insect bites while deployed 
by use of arthropod repellent, insecticide-impregnated 
clothing, and mosquito nets. The observation that rickett-
sial infections and Q fever might account for a sizeable 
proportion of cases of undifferentiated febrile illness seen 
in military field hospitals has led to the empirical use of 
doxycycline in such cases because Rickettsia and Coxiella 
species are sensitive to this drug. This practice justifies fur-
ther research on use of doxycycline for chemoprophylaxis 
in these instances.
More than half (56.7%) of volunteers who reported 
feeling unwell specifically reported a fever without other 
specific symptoms, which is consistent with the “undif-
ferentiated febrile illness” that the pathogens we inves-
tigated can cause. The 15.6% of volunteers reporting ill-
ness who reported diarrhea and vomiting could have had 
gastrointestinal infections; localized outbreaks of norovi-
rus and similar infections are common in military operat-
ing bases) (15). Of the many volunteers who experienced 
fever but did not show seroconversion for the 5 pathogens 
tested here, exposure to influenza virus or other respira-
tory infections should be considered. In 2011, Eick et 
al. reported that deployed US troops experienced 30.1% 
seroconversion for influenza and 6 other respiratory in-
fections (16). However, uptake of influenza vaccination, 
which is offered to UK military personnel before winter 
deployments, has increased for each of the past 4 years 
(2). Data from the militaries of other countries, which 
might have different deployment patterns and protective 
measures, should be compared only with caution. In addi-
tion, although some volunteers who seroconverted for all 
4 pathogens reported flu-like symptoms while deployed, 
we cannot ascertain whether these symptoms were a result 
of exposure to the pathogen of interest.
Some volunteers who seroconverted for the pathogens 
tested were asymptomatic for the duration of their deploy-
ments. Clinical disease probably did not develop in these 
patients, despite evidence of an exposure and an antibody 
response. Our finding that 65% of acute C. burnetii infec-
tions were asymptomatic is consistent with previous reports 
(17,18), but even in asymptomatic persons infected with 
this pathogen, long-term complications such as chronic Q 
fever and Q fever fatigue syndrome may develop. Overall, 
≈5% of acute cases progress to chronic Q fever, and com-
plications can include endocarditis requiring prolonged an-
timicrobial drug treatment and possibly heart valve surgery 
(19). In addition, Q fever fatigue syndrome may develop in 
≈20% of those infected (17), which is generally incompat-
ible with a military career and has substantial effects on 
patients’ quality of life. 
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Figure 3. Distribution of signs and symptoms among 90 UK service 
personnel who seroconverted to 1 of 4 infectious pathogens 
(sandfly fever virus, hantavirus, Coxiella burnetii, Rickettsia 
spp.) and who reported feeling ill during deployment to Helmand 
Province, Afghanistan, March 2008–October 2011.
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Royal et al. (20) recently reported C. burnetii serop-
revalence in US troops deployed to the Al Asad region of 
Iraq in 2005; a known Q fever outbreak occurred in this 
region at this time. This smaller study (n = 136) reported 
a 7.2% prevalence of C. burnetii infection among troops 
located in that area at the time of the outbreak. The report 
further supports (in addition to original work by Bailey et 
al. [13]) the C. burnetii seroprevalence reported here. Al-
though we did not see as high an incidence of seroconver-
sion, we were not specifically looking in an area with a 
known Q fever outbreak, merely an area in which Q fever 
is believed to be endemic.
Although this study did not find seroconversion for the 
viral hemorrhagic fever agent CCHFV, military and public 
health reports demonstrated that the virus is circulating in 
the region (21). In 2009, a US Army soldier in the neigh-
boring Kandahar Province died of CCHFV infection (22), 
and in 2012, a UK citizen returning from the northwest of 
the country also died (23,24).
In conclusion, this study highlights and confirms the 
potential for vector-borne and zoonotic diseases that are en-
demic in southern Afghanistan to emerge or reemerge to pose 
a substantial public health threats as the country rebuilds its 
public health infrastructure. A study of this type cannot give 
a specific indication of prevalence for these pathogens in the 
local population, but this surveillance can provide a valuable 
way of exploring emerging disease epidemiology, particu-
larly of vector-borne and zoonotic infections, in areas with 
poor public health reporting and infrastructure. Our findings 
of seroconversion for 4 of these pathogens among deployed 
UK troops reinforce the need for continued surveillance and 
continued education of health care providers so that, should 
military operations or environmental factors change in such 
a way that these modest incidence numbers increase, costly 
outbreaks can be avoided. This study also highlights the need 
for rapid, field-capable, point-of-care diagnostics in regions 
or situations for which full laboratory diagnostic facilities 
are not practical or available. 
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